Table 1.
Variable | Number (%) |
---|---|
Gender | |
Male | 9,841 (70.6%) |
Female | 4,101 (29.4%) |
Race/ethnicity | |
White | 4,210 (30.2%) |
Black | 6,489 (46.5%) |
Hispanic | 3,059 (21.9%) |
Other | 184 (1.3%) |
HIV transmission risk | |
MSM | 5,391 (38.7%) |
IDU | 1,731 (12.4%) |
Heterosexual | 4,290 (30.8%) |
Heterosexual-IDU | 1,109 (7.9%) |
MSM-IDU | 604 (4.3%) |
Other | 374 (2.7%) |
Missing | 443 (3.2%) |
Age | |
18–34 | 3,056 (21.9%) |
35–49 | 8,558 (61.4%) |
50 and older | 2,328 (16.7%) |
Lowest CD4 in period 1 | |
≤50 | 788 (5.7%) |
51≤CD4≤200 | 1,747 (12.5%) |
201≤CD4≤500 | 3,899 (28.0%) |
>500 | 2,521 (18.1%) |
No test reported | 4,987 (35.8%) |
Insurance in period 1 | |
Private | 1,391 (10.0%) |
Medicaid | 4,766 (34.2%) |
Medicare | 1,544 (11.1%) |
Uninsured/Ryan White | 2,540 (18.2%) |
Missing | 3,701 (26.6%) |
HIV-1 RNA in period 1 | |
>400 copies/ml | 5,396 (38.7%) |
≤400 copies/ml | 4,131 (29.6%) |
No Test reported | 4,415 (31.7%) |
HAART in period 1 | |
No | 4,787 (34.3%) |
Yes | 9,155 (65.7%) |
HAART, highly active antiretroviral therapy; IDU, injection drug use; MSM, men who had sex with men.